2022-04-012023-03-312023-03-31false06486954CLIFTON DENTAL PRACTICE LIMITED2023-12-15iso4217:GBPxbrli:pure064869542022-04-01064869542023-03-31064869542022-04-012023-03-31064869542021-04-01064869542022-03-31064869542021-04-012022-03-3106486954bus:SmallEntities2022-04-012023-03-3106486954bus:AuditExempt-NoAccountantsReport2022-04-012023-03-3106486954bus:FullAccounts2022-04-012023-03-3106486954bus:PrivateLimitedCompanyLtd2022-04-012023-03-3106486954core:WithinOneYear2023-03-3106486954core:AfterOneYear2023-03-3106486954core:WithinOneYear2022-03-3106486954core:AfterOneYear2022-03-3106486954core:ShareCapital2023-03-3106486954core:SharePremium2023-03-3106486954core:RevaluationReserve2023-03-3106486954core:OtherReservesSubtotal2023-03-3106486954core:RetainedEarningsAccumulatedLosses2023-03-3106486954core:ShareCapital2022-03-3106486954core:SharePremium2022-03-3106486954core:RevaluationReserve2022-03-3106486954core:OtherReservesSubtotal2022-03-3106486954core:RetainedEarningsAccumulatedLosses2022-03-3106486954core:LandBuildings2023-03-3106486954core:PlantMachinery2023-03-3106486954core:Vehicles2023-03-3106486954core:FurnitureFittings2023-03-3106486954core:OfficeEquipment2023-03-3106486954core:NetGoodwill2023-03-3106486954core:IntangibleAssetsOtherThanGoodwill2023-03-3106486954core:ListedExchangeTraded2023-03-3106486954core:UnlistedNon-exchangeTraded2023-03-3106486954core:LandBuildings2022-03-3106486954core:PlantMachinery2022-03-3106486954core:Vehicles2022-03-3106486954core:FurnitureFittings2022-03-3106486954core:OfficeEquipment2022-03-3106486954core:NetGoodwill2022-03-3106486954core:IntangibleAssetsOtherThanGoodwill2022-03-3106486954core:ListedExchangeTraded2022-03-3106486954core:UnlistedNon-exchangeTraded2022-03-3106486954core:LandBuildings2022-04-012023-03-3106486954core:PlantMachinery2022-04-012023-03-3106486954core:Vehicles2022-04-012023-03-3106486954core:FurnitureFittings2022-04-012023-03-3106486954core:OfficeEquipment2022-04-012023-03-3106486954core:NetGoodwill2022-04-012023-03-3106486954core:IntangibleAssetsOtherThanGoodwill2022-04-012023-03-3106486954core:ListedExchangeTraded2022-04-012023-03-3106486954core:UnlistedNon-exchangeTraded2022-04-012023-03-3106486954core:MoreThanFiveYears2022-04-012023-03-3106486954core:Non-currentFinancialInstruments2023-03-3106486954core:Non-currentFinancialInstruments2022-03-3106486954dpl:CostSales2022-04-012023-03-3106486954dpl:DistributionCosts2022-04-012023-03-3106486954core:LandBuildings2022-04-012023-03-3106486954core:PlantMachinery2022-04-012023-03-3106486954core:Vehicles2022-04-012023-03-3106486954core:FurnitureFittings2022-04-012023-03-3106486954core:OfficeEquipment2022-04-012023-03-3106486954dpl:AdministrativeExpenses2022-04-012023-03-3106486954core:NetGoodwill2022-04-012023-03-3106486954core:IntangibleAssetsOtherThanGoodwill2022-04-012023-03-3106486954dpl:GroupUndertakings2022-04-012023-03-3106486954dpl:ParticipatingInterests2022-04-012023-03-3106486954dpl:GroupUndertakingscore:ListedExchangeTraded2022-04-012023-03-3106486954core:ListedExchangeTraded2022-04-012023-03-3106486954dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-04-012023-03-3106486954core:UnlistedNon-exchangeTraded2022-04-012023-03-3106486954dpl:CostSales2021-04-012022-03-3106486954dpl:DistributionCosts2021-04-012022-03-3106486954core:LandBuildings2021-04-012022-03-3106486954core:PlantMachinery2021-04-012022-03-3106486954core:Vehicles2021-04-012022-03-3106486954core:FurnitureFittings2021-04-012022-03-3106486954core:OfficeEquipment2021-04-012022-03-3106486954dpl:AdministrativeExpenses2021-04-012022-03-3106486954core:NetGoodwill2021-04-012022-03-3106486954core:IntangibleAssetsOtherThanGoodwill2021-04-012022-03-3106486954dpl:GroupUndertakings2021-04-012022-03-3106486954dpl:ParticipatingInterests2021-04-012022-03-3106486954dpl:GroupUndertakingscore:ListedExchangeTraded2021-04-012022-03-3106486954core:ListedExchangeTraded2021-04-012022-03-3106486954dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2021-04-012022-03-3106486954core:UnlistedNon-exchangeTraded2021-04-012022-03-3106486954core:NetGoodwill2023-03-3106486954core:IntangibleAssetsOtherThanGoodwill2023-03-3106486954core:LandBuildings2023-03-3106486954core:PlantMachinery2023-03-3106486954core:Vehicles2023-03-3106486954core:FurnitureFittings2023-03-3106486954core:OfficeEquipment2023-03-3106486954core:AfterOneYear2023-03-3106486954core:WithinOneYear2023-03-3106486954core:ListedExchangeTraded2023-03-3106486954core:UnlistedNon-exchangeTraded2023-03-3106486954core:ShareCapital2023-03-3106486954core:SharePremium2023-03-3106486954core:RevaluationReserve2023-03-3106486954core:OtherReservesSubtotal2023-03-3106486954core:RetainedEarningsAccumulatedLosses2023-03-3106486954core:NetGoodwill2022-03-3106486954core:IntangibleAssetsOtherThanGoodwill2022-03-3106486954core:LandBuildings2022-03-3106486954core:PlantMachinery2022-03-3106486954core:Vehicles2022-03-3106486954core:FurnitureFittings2022-03-3106486954core:OfficeEquipment2022-03-3106486954core:AfterOneYear2022-03-3106486954core:WithinOneYear2022-03-3106486954core:ListedExchangeTraded2022-03-3106486954core:UnlistedNon-exchangeTraded2022-03-3106486954core:ShareCapital2022-03-3106486954core:SharePremium2022-03-3106486954core:RevaluationReserve2022-03-3106486954core:OtherReservesSubtotal2022-03-3106486954core:RetainedEarningsAccumulatedLosses2022-03-3106486954core:NetGoodwill2021-04-0106486954core:IntangibleAssetsOtherThanGoodwill2021-04-0106486954core:LandBuildings2021-04-0106486954core:PlantMachinery2021-04-0106486954core:Vehicles2021-04-0106486954core:FurnitureFittings2021-04-0106486954core:OfficeEquipment2021-04-0106486954core:AfterOneYear2021-04-0106486954core:WithinOneYear2021-04-0106486954core:ListedExchangeTraded2021-04-0106486954core:UnlistedNon-exchangeTraded2021-04-0106486954core:ShareCapital2021-04-0106486954core:SharePremium2021-04-0106486954core:RevaluationReserve2021-04-0106486954core:OtherReservesSubtotal2021-04-0106486954core:RetainedEarningsAccumulatedLosses2021-04-0106486954core:AfterOneYear2022-04-012023-03-3106486954core:WithinOneYear2022-04-012023-03-3106486954core:Non-currentFinancialInstrumentscore:CostValuation2022-04-012023-03-3106486954core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-04-012023-03-3106486954core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-04-012023-03-3106486954core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-04-012023-03-3106486954core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-04-012023-03-3106486954core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-04-012023-03-3106486954core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-04-012023-03-3106486954core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-04-012023-03-3106486954core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-04-012023-03-3106486954core:Non-currentFinancialInstrumentscore:CostValuation2023-03-3106486954core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-03-3106486954core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-03-3106486954core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-03-3106486954core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-03-3106486954core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-03-3106486954core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-03-3106486954core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-03-3106486954core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-03-3106486954core:Non-currentFinancialInstrumentscore:CostValuation2022-03-3106486954core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-03-3106486954core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-03-3106486954core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-03-3106486954core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-03-3106486954core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-03-3106486954core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-03-3106486954core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-03-3106486954core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-03-3106486954bus:Director12022-04-012023-03-3106486954core:FurnitureFittingsToolsEquipment2022-03-3106486954core:FurnitureFittingsToolsEquipment2022-04-012023-03-3106486954core:FurnitureFittingsToolsEquipment2023-03-31

CLIFTON DENTAL PRACTICE LIMITED

Registered Number
06486954
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2023

CLIFTON DENTAL PRACTICE LIMITED
Company Information
for the year from 1 April 2022 to 31 March 2023

Director

HUSSAIN, Altaf, Dr

Registered Address

The Crescent Dental & Implant Centre Asr Finance Office
The Crescent
Selby
YO8 4PE

Registered Number

06486954 (England and Wales)
CLIFTON DENTAL PRACTICE LIMITED
Statement of Financial Position
31 March 2023

Notes

2023

2022

£

£

£

£

Fixed assets
Intangible assets651,12062,400
Tangible assets728,8178,839
79,93771,239
Current assets
Stocks81,7511,070
Debtors920,70361,299
Cash at bank and on hand134,17623,022
156,63085,391
Creditors amounts falling due within one year10(67,923)(53,552)
Net current assets (liabilities)88,70731,839
Total assets less current liabilities168,644103,078
Provisions for liabilities11(5,475)-
Net assets163,169103,078
Capital and reserves
Called up share capital100100
Profit and loss account163,069102,978
Shareholders' funds163,169103,078
The financial statements were approved and authorised for issue by the Director on 15 December 2023, and are signed on its behalf by:
HUSSAIN, Altaf, Dr
Director
Registered Company No. 06486954
CLIFTON DENTAL PRACTICE LIMITED
Notes to the Financial Statements
for the year ended 31 March 2023

1.Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
2.Compliance with applicable reporting framework
These financial statements have been prepared in compliance with FRS 102 Section 1A, The Financial Reporting Standard applicable in the UK and Republic of Ireland.
3.Principal activities
The principal activity of the company during the year was that of a dental practice.
4.Accounting policies
Property, plant and equipment policy
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

Reducing balance (%)
Fixtures and fittings15
Intangible assets policy
Intangible assets are initially recorded at cost, and are subsequently stated at cost less any accumulated amortisation and impairment losses. Any intangible assets carried at revalued amounts, are recorded at the fair value at the date of revaluation, as determined by reference to an active market, less any subsequent accumulated amortisation and subsequent accumulated impairment losses. Intangible assets acquired as part of a business combination are only recognised separately from goodwill when they arise from contractual or other legal rights, are separable, the expected future economic benefits are probable and the cost or value can be measured reliably.
Stocks policy
Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all cost of purchase, cost of conversion and other costs incurred in bringing the stock to its present location and condition.
Revenue recognition policy
The revenue shown in the profit and loss account represents income receivable from dental treatments carried out during the period. Revenue in respect of dental treatment uncompleted at the year end date is recognised by reference to the state of completion.
Deferred tax policy
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted, or substantively enacted, by the reporting date that are expected to apply to the reversal of the timing difference.
Employee benefits policy
Contributions to defined contribution plans are expensed in the period to which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund. When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised as a finance cost in profit or loss in the period in which it arises.
Going concern
Following the challenges arising as a consequence of the Covid-19 pandemic in 2020/21, more latterly the UK economy has been impacted by rising inflation, interest rates and energy costs, exacerbated by the war in Ukraine. All these matters have impacted the company’s trading results to a greater or lesser extent. At the date of signing these financial statements, the directors have considered the effect of these matters on the company with the information available to it, and do not believe that it will affect the ability of the company to continue to trade for the foreseeable future. On this basis, the directors have prepared these financial statements on a going concern basis.
5.Employee information

20232022
Average number of employees during the year810
6.Intangible assets

Goodwill

Other

Total

£££
Cost or valuation
At 01 April 22156,000-156,000
Additions-4,8004,800
At 31 March 23156,0004,800160,800
Amortisation and impairment
At 01 April 2293,600-93,600
Charge for year15,60048016,080
At 31 March 23109,200480109,680
Net book value
At 31 March 2346,8004,32051,120
At 31 March 2262,400-62,400
7.Property, plant and equipment

Fixtures & fittings

Total

££
Cost or valuation
At 01 April 2248,00748,007
Additions25,06325,063
At 31 March 2373,07073,070
Depreciation and impairment
At 01 April 2239,16839,168
Charge for year5,0855,085
At 31 March 2344,25344,253
Net book value
At 31 March 2328,81728,817
At 31 March 228,8398,839
8.Stocks

2023

2022

££
Other stocks1,7511,070
Total1,7511,070
9.Debtors

2023

2022

££
Trade debtors / trade receivables13,49410,822
Other debtors7,20950,477
Total20,70361,299
10.Creditors within one year

2023

2022

££
Trade creditors / trade payables38,0525,348
Amounts owed to related parties5,1441,103
Taxation and social security12,70143,201
Other creditors8,113-
Accrued liabilities and deferred income3,9133,900
Total67,92353,552
11.Provisions for liabilities

2023

2022

££
Net deferred tax liability (asset)5,475-
Total5,475-